Emkay Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Explore Now
Mumbai: Punters are circling back to shares of companies that would benefit the most from the second wave of Covid-19. Many of these stocks had gone out of favour in recent months with the infections receding. Now, with the virus making a comeback, companies dealing in oxygen or medical equipment supplies, manufacturers of Covid-19 drugs, vaccine makers, and diagnostic centres among others are back in focus. ET has compiled a list of such stocks that are currently in the limelight.
Cipla with nearly 50% market share of Remdesivir has doubled its production to meet incremental demand. This coupled with increase in production of vaccines will yield short- to medium-term benefits by way of higher revenues. “Cipla is well positioned to deliver strong earnings growth over the medium term with incremental respiratory launches/filings and continued execution in domestic business through its One India strategy,” said Kumar Gaurav, analyst, Kotak Securities. ....

Dhirendra Tiwari , Kunal Dhamesha , Siddhant Khandekar , Cadila Zyco , Kumar Gaurav , Ankush Mahajan , Everest Kanto , Syngene International , One India , Linde India , Antique Stock , Cadila Healthcare , Emkay Stock , திரென்திற திவாரி , சித்தாந்த் கண்டெகர் , குமார் கௌராவ் , அங்குஷ் மகாஜன் , எவரெஸ்ட் கான்டோ , ஒன்று இந்தியா , லிண்டே இந்தியா , பழங்கால ஸ்டாக் , காடிலா சுகாதாரம் ,